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Modular Synthesis of Self-Assembling Janus-Dendrimers and 
Facile Preparation of Drug-Loaded Dendrimersomes 
Sami Nummelin*a, Markus Selinb, Sacha Legrand ?c, Jarmo Ropponen*c, Jani Seitsonend, Antti 
Nykänend, Jari Koivistoe, Jouni Hirvonenb, Mauri A. Kostiainena, Luis M. Bimbo*b,f 
Materials and methods aimed at the next generation of nanoscale carriers for drugs and other therapeutics are currently in 
great demand. Yet, creating these precise molecular arrangements in a feasible and straightforward manner represents a 
remarkable challenge. Herein we report a modular synthetic route for amphiphilic Janus-dendrimers via a copper-catalyzed 
click reaction (CuAAC) and a facile procedure, using simple injection, to obtain highly uniform dendrimersomes with efficient 
loading of the model drug compound propranolol. The resulting assemblies were analyzed by dynamic light scattering and 
cryogenic transmission electronic microscopy revealing the formation of unilamellar and multilamellar dendrimersomes. 
The formation of a bilayer structure was confirmed using cryo-TEM and confocal microscopy visualization of an encapsulated 
solvatochromic dye (Nile red). The dendrimersomes reported here are tunable in size, stable over time and display robust 
thermal stability in aqueous media. Our results expand the scope of dendrimer-based supramolecular colloidal systems and 
offer the means for one-step fabrication of drug-loaded dendrimersomes in the size range of 90 ?200 nm, ideal for 
biomedical applications. 
 
Introduction 
Nanoscale drug carriers1 that facilitate drug transport through 
different compartments and across biological barriers2,3 have 
emerged as attractive structures for biomedical purposes due 
to their unique and distinct features e.g. high surface to volume 
ratio, possibility to increase circulation half-life, modulation of 
the pharmacokinetic profile of drugs, improved efficacy and 
reduced off-target toxicity.4 ?6 Liposomes, for instance, are 
dynamic supramolecular capsules self-assembled in aqueous 
media from natural or synthetic phospholipids, whose potential 
has already been capitalized by several formulations currently 
on the market.7 Polymersomes, on the other hand, are vesicles 
assembled from amphiphilic block copolymers. They are more 
robust than liposomes and have also found use in several 
applications in the biomedical field.8 Although extensively 
studied and displaying great potential, common to these 
architectures is that they can suffer from shortcomings that 
have so far hindered a more effective translation such as broad 
size distribution, high production costs due to complex 
preparation and purification methodologies,9,10 limited long-
term colloidal stability, as well as some toxicity concerns in the 
case of polymersomes. These problems are not exclusive to 
liposomes or polymersomes, as designing modular synthetic 
nanoparticulate systems with target-specific functions 
represents a remarkable challenge.7,11 
Dendritic molecules are broadly approved as the fourth class of 
polymers in addition to linear, crosslinked, and branched 
polymeric structures.12,13 Dendrimers and dendrons14,15 are 
technologically advanced synthetic macromolecules having 
intrinsic structural and topological features, e.g. enhanced 
solubility, periodically branched primary structure and high 
structural uniformity.16,17 A myriad of functional groups can be 
precisely positioned throughout the skeleton, generating 
unparalleled structural versatility.18 Multivalent dendrimers 
and dendrons can readily serve as powerful structure-directing 
tectons, transfer and amplify chirality,19 ?21 and thus mediate the 
formation of hierarchically ordered assemblies and other 
complex systems that mimic important biological 
structures.18,22 ?25 
Amphiphilic Janus-dendrimers are particularly interesting 
architectures.26 ?31 Percec et al. discovered that such 
amphiphiles readily self-assemble into uniform and robust 
unilamellar vesicles, denoted as dendrimersomes, via simple 
injection from various organic solutions into water or biological 
buffers.25 The resulting dendrimersomes exhibit excellent 
mechanical properties. Moreover, their size and morphology 
can be modulated and even predicted with high correlation to 
experimental data.32 ?34 The repertoire has been further 
ĞǆƉĂŶĚĞĚ ǁŝƚŚ  “ƐŝŶŐůĞ-ƐŝŶŐůĞ ? :ĂŶƵƐ-dendrimers33 ?36 and 
carbohydrate-terminated amphiphilic Janus-dendrimers 
(glycodendrimersomes), which can form a variety of hard and 
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soft bilayer vesicles37 ?41 and multilayer vesicles34,41 that mimic 
biological membranes and bind selectively to biomedically 
relevant lectins. Dendrimersomes have been successfully 
loaded with dye molecules25,42 and contrast agents for MRI 
applications,35,36,43 but examples with therapeutic drugs 
molecules are yet sparse. So far, only doxorubicin loaded via 
film hydration,25 plitidepsin loaded via an oil-in-water 
method,27 and the glucocorticoid drug prednisolone phosphate 
together with a MRI agent in vivo35 have been reported. The 
drug loading methods for all reported studies entail several 
experimental steps. Therefore, a fast and convenient loading of 
therapeutics within dendrimersomes remains elusive. 
Herein we present a modular synthetic route for amphiphilic 
Janus-dendrimers using click-chemistry and the straightforward 
procedure, using simple injection, to obtain uniform 
dendrimersomes via simultaneous self-assembly and 
encapsulation of propranolol, a small molecule model drug. 
Results and Discussion 
Design and Synthesis of Amphiphilic Janus-dendrimers 
In this work six amphiphilic Janus-dendrimers were synthesized 
by facile coupling of first generation hydrophobic Percec-type 
dendrons22,31 with two generations of hydrophilic 2,2-
bis(hydroxymethyl) propionic acid (bis-MPA) dendrons using 
click-chemistry.44 Three hydrophobic dendrons 5a-c were 
synthesized in four steps (Scheme 1), starting from methyl 3,4-
dihydroxybenzoate, methyl 3,5-dihydroxybenzoate, and methyl 
3,4,5-trihydroxybenzoate 1a-c respectively. Alkylation of the 
benzoates with 1-bromododecane gave the first generation 
dendrons 2a-c with methyl ester at the apex. Corresponding 
alcohols 3a-c were obtained by reduction with lithium 
aluminium hydride in dry tetrahydrofuran (THF). Subsequent 
chlorination with thionyl chloride in dichloromethane (CH2Cl2) 
followed by reaction with sodium azide in dimethylformamide 
(DMF) produced the target dendrons having an azide moiety at 
the focal point in 87 % 5a, 56 % 5b and 79 % 5c overall yield, 
respectively. 
The first and second generation hydrophilic building blocks 
having propargyl moiety inserted at the apex were constructed 
of bis-MPA (Scheme 2).45,46 The bis-MPA dendron was selected 
as the hydrophilic block to replace the widely used 
poly(ethylene glycol), in view of a recent study which reported 
its excellent biocompatibility and stability.47 The G1 dendron 8 
was synthesized in two steps from 6 by N,N-dicyclohexyl 
carbodiimide (DCC) esterification48 using 4-(dimethylamino) 
pyridinium p-toluenesulfonate (DPTS) as the catalyst in dry 
CH2Cl2 followed by removal of acetal-protection with Dowex 
50W-X2 resin in methanol (87 % overall yield). An anhydride 
coupling strategy was employed for enhanced reactivity and 
ease of purification for the subsequent generation G2. The 
acetonide protected bis-MPA 6 was converted into the 
corresponding anhydride of isopropylidene-2,2-bis(methoxy) 
propionic acid through self-dehydration using DCC in 
dichloromethane (77 % yield). Reaction with 8 and removal of 
the acetal protection gave the G2 dendron 10 in 79% overall 
yield over four steps. The copper(I)-catalyzed azide alkyne 
cycloaddition (CuAAC) reactions were performed in vials using 
a THF:H2O:DMSO mixture as solvent media in the presence of 
Cu(II)SO4 and sodium-L-ascorbate. After the completion of the 
reactions, crude products were purified by flash 
chromatography on SiO2 (CH2Cl2/MeOH) affording the target 
Janus-dendrimers 11a-c and 12a-c in 92 ?97 % yields. The purity 
of the final products was higher than 99 %, as demonstrated by 
a combination of thin layer chromatography (TLC), 1H-NMR, 13C-
NMR, size exclusion chromatography (SEC), mass spectrometry 
(ESI-TOF-MS), and elemental analysis (Supporting information). 
The final products were extracted with 1 M 
ethylenediaminetetraacetic acid (EDTA) solution to remove any 
traces of copper. The copper residues were found to be below 
35 ppm, as detected by flame Atomic Absorption Spectrometry 
(AAS) after EDTA treatment, which are reportedly acceptable 
levels for future biological applications.49 All amphiphilic Janus-
dendrimers and their short notations are illustrated in Fig. 1. 
 
Self-Assembly of Janus-Dendrimers in Aqueous Solution 
Dynamic Light Scattering (DLS) analysis 
All Janus-dendrimers were readily soluble in ethanol, THF and 
acetone. The injection of Janus-dendrimers from an organic 
solution into water is an easy and straightforward method to 
fabricate dendrimersomes, in contrast to the film hydration 
technique which entails a more extensive experimental 
procedure. The Z-average size, polydispersity index (PDI), and 
stability over time and temperature of the resulting assemblies 
were investigated by DLS experiments. 
Scheme 1. Synthesis of hydrophobic AB2- and AB3-branched Percec-type dendrons a 
 
a Reagents and conditions: i) C12H25Br, K2CO3, DMF, 70 °C, 8 h; ii) LiAlH4, THF, 0 to 25 °C, 6 h; iii) SOCl2, cat DMF, CH2Cl2, 2 h; iv) NaN3, DMF, 80 °C, 6 h. 
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Scheme 2. Synthesis of hydrophilic propargyl-modified bis-MPA dendrons b 
b Reagents and conditions: i) propargyl alcohol, DPTS, DCC, CH2Cl2 rt, 16 h; ii) DOWEX H+, MeOH, 40 °C, 5 h; iii) anhydride of isopropylidene-2,2-bis(methoxy) propionic, 
DMAP, pyridine, CH2Cl2, rt, 12 h. 
 
 
 
Fig. 1. Amphiphilic Janus-dendrimers, their short notations and summary of the assemblies in Milli-Q®. The diameter (Z-avg. size in nm) and polydispersity index (in 
parenthesis) were measured by DLS (c = 0.5 mg mL-1). Indicated morphologies were determined by cryo-TEM. 
 
In general, fast injection from a dilute ethanol solution (10 mg 
mL-1) into Milli-Q® (final concentrations 0.1 ?4.0 mg mL-1) 
produced highly uniform dendrimersomes with Z-average sizes 
ranging from 58 nm to 315 nm and PDI from 0.06 to 0.23 (Figs. 
S8 ?S13, Supporting Information). No additional purification was 
applied. The PDI values were remarkably low and below the 
threshold value 0.2 that is considered monodisperse for vesicles 
(PDI=0 corresponds to a uniform size distribution).25 Injection 
from a dilute THF and acetone solutions (5 mg mL-1) into Milli-
Q® (c = 0.1 ?1.0 mg mL-1) produced assemblies in the size range 
of 118 ?350 nm (PDI 0.04 ?0.12) (Figs. S14 ?S19, Supporting 
Information) and 56 ?249 nm (PDI 0.02 ?0.32) (Figs. S20 ?S25, 
Supporting Information), respectively. The 3,4-G1 (11a) 
dendrimers precipitated immediately when injected from 
ethanol (10 mg mL-1) into Milli-Q® at various concentrations. 
However, assemblies were formed when 11a was injected from 
a more diluted ethanolic stock solution (5 mg mL-1). The 
formation of assemblies in solution is a fast self-assembling 
process.32 We postulate that the slow dynamics of assembly of 
3,4-G1 (11a) results in aggregation before ordered structures 
can be formed in solution, probably due to the combination of 
unfavourable conformation and high local concentration of 11a 
in solution. Janus-dendrimers injected from an ethanol solution 
exhibited monomodal size distribution in the reported 
concentration range. The only exceptions were 3,4-G2 (12a, c = 
4.0 mg mL-1), which formed gel during the DLS measurement, 
and 3,4,5-G2 (12c, c = 2.0 mg mL-1) which showed broad size 
distribution (PDI 0.37). All samples had negative electrokinetic 
potential in Milli-Q®, having measured ]-potentials ranging 
from -18.7 to -9.8 mV (Table S1, Supporting Information). As a 
general trend, we observed a clear dependence of size of 
dendrimersomes vs. final concentration of dendrimers which 
can be further seen in Fig. S26 (Supporting Information), where 
we injected the dendrimers from ethanolic stock solutions with 
different dendrimer concentrations into Milli-Q®. When 
injected from ethanol, THF or acetone into Milli-Q®, the Z-
average size increased with concentration, while PDI remained 
extremely low (mostly below 0.10). Furthermore, assembly size 
was dependent on branching sequence and the solvent media 
from which they were injected (Figures S8-S26, Supporting 
Information). This discovery of size modulation is an important 
asset for future applications, since the accumulation of 
liposomes2,50 and the drug release profile from liposomes in vivo 
has been shown to be size-dependent.51 A size range of 90 ?200 
nm is thought to be desirable for most intravenous drug delivery 
applications,52 with the dendrimersomes produced in this study 
falling within that range. It should be mentioned, however, that 
for some applications the dendrimersome concentrations 
studied here are low, i.e. if dendrimersomes are to be loaded 
with low potency compounds at these concentrations, the 
system might not achieve clinical efficacy once administered. 
Next, we investigated the stability and the size distribution of 
assemblies as a function of temperature and time. All samples 
were prepared via injection from ethanol (c = 0.5 mg mL-1) and 
annealed from 25 °C to 70 °C. We excluded 3,4-G1 (11a) and 3,4-
G2 (12a), which were unstable after injection and over time. The 
results show excellent thermal stability with no considerable 
budding or merging observed (Fig. 2a). Notably, G2 dendrimer-
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based structures 3,5-G2 (12b) and 3,4,5-G2 (12c) (Fig. 2a in red) 
retained their size and PDI during the annealing, having a Z-
average size and PDI (in parenthesis) of 86±3 nm (0.06±0.02) for 
3,5-G2 and 77±2 nm (0.04±0.01) for 3,4,5-G2 throughout the 
whole temperature range. The robust thermal stability is 
remarkable and comparable to polymersomes having much 
thicker bilayer wall.53 The stability of the assemblies over time 
obtained via ethanol injection (c = 0.5 mg mL-1) was also 
monitored at 25 °C (Fig. 2b). The structures self-assembled from 
Janus-dendrimers having 3,5- or 3,4,5-branching sequence 
were stable and uniform in size up to 130 days (d) and beyond, 
whereas 3,4-G1 (11a) assemblies were stable only 22 d and 3,4-
G2 (12a) 11 d (data not shown). 
 
Fig. 2 a) Stability of the assemblies as a function of temperature; b) Stability of assembly 
size over time at ambient temperature. Janus-dendrimers were injected from ethanol (c 
= 0.5 mg mL-1) in Milli-Q® and measured in triplicate at each temperature and time point. 
Error bars represent ±SD. 
Likewise, we monitored the stability over time of all six 
structures injected from THF and acetone in ambient 
temperature. Janus dendrimers injected from THF into Milli-Q® 
produced higher Z-average size when compared to the 
injections from ethanol or acetone. The 3,4-G1 (11a) were 
stable for 11 d when injected from THF (Fig. S27), and only for 5 
d when injected from acetone (Fig. S28). However, the 3,4-G2 
(12a) assembly lasted 22 d (injected from THF) before visible 
particles emerged (Fig. S27). The 3,4-G2 (12a) injected from 
acetone formed the most stable assembly of all 3,4-branched 
Janus-dendrimers lasting nearly 90 d (Fig. S28). However, after 
ca. 50 d, the particle size almost doubled from the initial 115 nm 
to 226 nm, suggesting merging and aggregation before 
precipitation. The poor stability of 3,4-G1 and 3,4-G2 is in 
agreement with related 3,4-branched structures reported by 
Filippi et al.35,36 We assume that this is likely due to the different 
packing motif of the constituting alkyl tails of the 3,4-branching 
sequence, which are less imbricated or interdigitated than the 
3,5- or 3,4,5-branched structures.32 Therefore, the dynamic 
processes within the bilayer involving amphiphile exchange via 
diffusion require less energy and can result in lower stability of 
these assemblies.54 Moreover, we investigated the stability of 
the dendrimersomes in a biologically relevant setting. Only 
stable (in Milli-Q®) Janus-dendrimers 11b,c and 12b,c were 
injected into Milli-Q® (c = 3 mg mL-1) followed by dilution in 
Foetal Bovine Serum (FBS) in a 1:9 ratio. Samples were 
incubated at 37 °C and the Z-average size (Fig. 3a) and PDI (Fig. 
3b) were measured each day for seven days. As it happens with 
liposomes, the size of the dendrimersomes increases when in 
contact with serum proteins, as the proteins surround the 
nanostructures leading to the formation of a rich protein shell 
ƚĞƌŵĞĚ  “ƉƌŽƚĞŝŶ ĐŽƌŽŶĂ ? ?55 dŚŝƐ  “ĐŽƌŽŶĂ ? ŝŶĨůƵĞŶĐĞƐ ƚŚĞ
interactions between nanoparticles and living cells, effectively 
determining what is "seen" by the living organism.56 The Z-
average sizes of 3,5-G1 (260±20 nm), 3,4,5-G1 (180±10 nm), 3,5-
G2 (275±30 nm) and 3,4,5-G2 (220±40 nm) were measured over 
the course of seven days (Fig. 3a). PDI variation between -20 % 
and +20 % of the value at day one for the first generation and -
70 % and +70 % for the second generation was also observed 
(Fig. 3b). Dendrimersomes based on similar architecture 
displayed comparable behaviour and were deemed suitable for 
intravenous administration.35,36 
 
Fig. 3 a) Stability of the assemblies as a function of time in FBS. b) Change (%) in 
polydispersity index (PDI) over time (7d). Janus-dendrimers were injected from ethanol 
into Milli-Q® (c = 3 mg mL-1) and then diluted in FBS for a final concentration of 90% FBS. 
All samples were measured in triplicate at each time point. Error bars represent ±SD. 
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Fig. 4 Representative cryo-TEM images illustrating dendrimersomes self-assembled via injection of their ethanolic solutions into Milli-Q® (c = 0.5 mg mL-1, respectively, except for 
3,5-G2 where c = 0.125 mg mL-1). Values of bilayer thicknesses for G2-dendrimersomes are an average of ten measurements. Scale bars are 100 nm. 
Elucidation of the assemblies using microscopic methods 
Structures in aqueous solution were investigated by cryogenic 
transmission electron microscopy (cryo-TEM). Samples were 
freshly prepared via injection from an ethanol solution (100 µL 
of 5 mg mL-1) into 900 µL of Milli-Q®, with a final concentration 
of 0.5 mg mL-1, except 3,5-G2 (c = 0.125 mg mL-1). Cryo-TEM 
images with measured bilayer thicknesses for G2-
dendrimersomes are shown in Fig. 4. We could discern both 
unilamellar dendrimersomes (11a,b and 12a-c) and 
multilamellar dendrimersomes (11c) which resemble the onion-
like structures reported by Percec group.34,41 Additional images 
illustrating ƚŚĞĚĞŶĚƌŝŵĞƌƐŽŵĞƐ ?uniform size distribution are 
shown in Fig. S29 (Supporting Information). However, the cryo-
TEM images also showed that 3,5-G2 (12b) structures, besides 
having a uniform population (S30a), also displayed a number of 
hollow-core multilayer dendrimersomes (S30b). These 
structures are substantially different from the 3,4,5-G1 
structures depicted in Fig. 4 and as samples at lower 
concentrations were imaged, this phenomenon drastically 
diminished. We hypothesize that this is most likely due to the 
cryo-TEM sample preparation method, where the structures 
were disrupted during the blotting procedure and when the 
bilayer is re-formed in a more concentrated volume, these new 
structures were generated. 
The higher generation structures having eight (G3) or sixteen 
(G4) hydroxyl groups at the periphery did not self-assemble into 
dendrimersomes (not shown). Instead, all three G3 structures 
self-assembled into fibres giving rise to mechanically robust 
supramolecular hydrogels in Milli-Q®, even at very low mass 
proportion (0.2% by mass).57 
The formation of a bilayer structure was further corroborated 
by the localization of a solvatochromic dye Nile Red (NR) within 
the dendrimersome wall of giant dendrimersomes (Fig. 5a). 
Giant unilamellar dendrimersomes (ca. 10 µm in size) with 
uniform spherical morphology (Fig. 5b) were obtained by film 
hydration,25 as seen by confocal microscopy imaging. The 
hollow cavity of these vesicles can also be visualized from the 
reconstitution of the collected z-stacks (Fig. 5c). 
 
Loading of dendrimersomes with a model drug 
Film hydration as a drug-loading method entails an extensive 
handling protocol, offers little control over assembly size and 
often produces structures with broad size distribution. 
Therefore, we postulated that a direct injection method could 
be a convenient and straightforward method for loading 
dendrimersomes with a payload of interest. In order to discern 
between free and encapsulated payload, the solvatochromic 
dye NR was loaded in dendrimersomes self-assembled from 
3,4,5-G1 (11c) or 3,5-G2 (12b). The NR acts as a hydrophobic 
probe, where its fluorescence maxima varies depending on the 
relative hydrophobicity of the surrounding environment, 
whereas in aqueous media NR fluorescence is completely 
quenched.58 
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Fig. 5 a) Confocal microscopy of Nile Red-encapsulated giant dendrimersomes 
assembled from 3,5-G2 (12b) obtained by film hydration (scale bar is 10 µm); b) 
individual giant ĚĞŶĚƌŝŵĞƌƐŽŵĞƐ ǁŝƚŚ EZ ŝŶƐŝĚĞ ƚŚĞ ǀĞƐŝĐůĞƐ ? ďŝůĂǇĞƌ ? Đ ?  ?
reconstruction of a dendrimersome from confocal z-stacks. 
The solutions of 11c or 12b, together with the NR mixture were 
injected into Milli-Q® (final c = 490 µg mL-1 of 11c or 12b and 
3.14 µM NR in 5 % (v/v) ethanol). As a control, NR was injected 
into Milli-Q® (neat or in 98 µL of pure ethanol) at the same ratios 
as with the dendrimersomes. We noticed that only the 11c and 
12b NR-dendrimer mixtures injected into in Milli-Q® had a red 
colour under visible light (Figs. 6a and S31 Supporting 
Information, respectively) and strong absorption under UV light 
(data not shown). The Z-average size of the NR-loaded 
dendrimersomes 3,4,5-G1 (11c: 72.8±0.5 nm, PDI 0.11) and 3,5-
G2 (12b: 87.6±1.1 nm, PDI 0.03) dropped to 14.4±0.5 nm and 
9.8±0.1 nm after addition of 500 µL of 3 % Triton X-100 per 1 mL 
of the solutions, thus confirming the disruption of the 
dendrimersomes. In comparison, the Z-avg. size of neat 
dendrimersome controls (11c: 76.0±0.9 nm, PDI 0.14; 12b: 
86.41±0.9 nm, PDI 0.05) dropped to 9.4±0.1 nm and 10.1±0.2, 
respectively. The fluorescence scan revealed that the NR-
loaded dendrimersomes had fluorescence maxima at 635 nm 
(Fig. 6b), unlike the controls, which showed no fluorescence 
throughout the entire measured wavelength range. The 
fluorescence spectra combined with the DLS and UV-irradiation 
results confirm the successful loading of NR into the 
dendrimersome bilayer. 
Next, we tested the feasibility of the injection method with the 
self-quenching drug propranolol free base. Propranolol (PR) is a 
basic compound with a pKa value 9.6859 that has been shown to 
associate with liposomal membranes at pH 7.4.60 Self-
quenching of propranolol fluorescence occurs at concentrations 
above 1 mM in aqueous solutions and increases as a function of 
the drug concentration. To obtain a fluorescent signal and to 
avoid self-quenching in the non-encapsulated proportion of 
propranolol, an overall concentration of 25 µM propranolol was 
used in the samples and in the fluorescence control. At this 
concentration, the calculated fluorescent lifetime of 
propranolol (16 ns) is above the empirical lifetimes reported in 
literature.61 The loading of PR within the bilayers of 
dendrimersomes was expected to increase the local 
concentrations of the drug and lead to self-quenching in the 
encapsulated proportion, and thereby the self-quenching was 
also expected to reduce the overall measurable fluorescence 
intensity. 
Solutions of 3,4,5-G1 (11c) and 3,5-G2 (12b) were mixed with 
PR solution and the mixtures were separately injected into Milli-
Q®, and PR in 10 % ethanol was used as the fluorescent control. 
This enabled the comparison of the fluorescence of free PR in 
the control and the overall fluorescence of PR in the 
ĚĞŶĚƌŝŵĞƌƐŽŵĞ ĐŽŶƚĂŝŶŝŶŐ ƐĂŵƉůĞƐ  ?ĨŝŶĂů Đ с  ? ? ? ʅŐ ŵ>-1 
dendrimer in 10 % (v/v) ethanol) at the same overall drug 
concentrations (Fig. 6c). The propranolol fluorescence was 
quenched in the presence of 3,4,5-G1 (11c) and 3,5-G2 (12b) 
dendrimersomes, and the quenching was stable through time. 
The relative fluorescence of the PR-loaded 11c dendrimersomes 
was slightly lower (ca. 15 %) than that of 12b dendrimersomes. 
Two things should be considered when interpreting this result. 
Firstly, the fraction of the total PR loaded into 3,4,5-G1 (11c) 
may be larger than the fraction of the total PR loaded into 3,5-
G2 (12b). As PR is mainly expected to be encapsulated in the 
bilayers constituting the dendrimersomes, the molar 
dendrimer-to-drug ratios (22.8 and 21.6 for the 11c and 12b, 
respectively) have some potential to cause higher PR-loading in 
the 11c than 12b dendrimersomes. Secondly, loading of similar 
fractions of the total PR may lead to higher local concentrations 
of PR in multilamellar 3,4,5-G1 (11c) than in 3,5-G2 (12b) 
dendrimersomes. Based on the size of the loaded 
dendrimersomes and the morphologies seen in cryo-TEM, we 
speculate that the multilamellar dendrimersomes 11c 
incorporate higher number of Janus-dendrimers per 
dendrimersome and, thus, are less numerous in solution at the 
same concentration than unilamellar 3,5-G2 (12b) 
dendrimersomes.  
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Fig. 6 a) Photograph of samples in the NR-loading experiment: Simple injection of 
I) Nile Red (NR), (II) Nile Red-ethanol mixture, (III) 3,4,5-G1 (11c), (IV) Nile Red-
loaded 3,4,5-G1 dendrimersomes in ethanol mixture, into Milli-Q®. All Nile Red 
and Janus-dendrimer 3,4,5-G1 concentrations were the same in the final volume; 
b) fluorescence of Nile Red loaded 3,4,5-G1 (11c) and 3,5-G2 (12b) 
dendrimersomes and controls; and c) Propranolol loading into 11c and 12b 
dendrimersomes (red and black, respectively) measured by relative fluorescence, 
i.e. the ratio of sample fluorescence and fluorescence control (blue, 25 µM 
propranolol in 10 % ethanol). The arrows denote the time when 50 µL 3% Triton 
X-100 solution was added in order to disrupt the samples and the control. Error 
bars represent ± SD (n=3). 
Therefore, the confinement of PR in the dendrimersomes lead 
to higher local concentrations of PR in 11c dendrimersomes 
than in 12b dendrimersomes which explains the lower relative 
fluorescence values measured for 11c compared to 12b before 
ĚĞŶĚƌŝŵĞƌƐŽŵĞĚŝƐƌƵƉƚŝŽŶ ?dŚĞĂĚĚŝƚŝŽŶŽĨ ? ?ʅ>ŽĨ ?йdƌŝƚŽŶ
X-100 solution per 200 µL of sample volume did not noticeably 
change the fluorescence intensity of the controls (data not 
shown), whereas the relative fluorescence values of the 
samples increased from 22.5±1.5 % to 71.7±0.6 % for 3,4,5-G1 
(11c), and from 37.3±1.6 % to 77.8±0.8 % for 3,5-G2 (12b), 
confirming the presence of the quenched PR in the samples (Fig. 
6c). The increase in the fluorescence shows that intact 
dendrimersomes are required for efficient self-quenching of 
propranolol fluorescence. We assume that the relative 
fluorescence in disrupted 3,4,5-G1 (11c) dendrimersome 
samples was lower than in disrupted 3,5-G2 (12b) 
dendrimersome samples due to the slight difference in the 
molar dendrimer-to-drug ratios. The fluorescence intensities of 
the samples did not reach the intensity of the control samples 
even after all the samples and controls were treated with the 
Triton X-100 solution. This indicates that stronger associations 
took place between the dendrimers and PR than between Triton 
X-100 and PR, and that the disruption of the dendrimersome 
bilayers was incomplete since the self-quenching local 
concentrations of PR were maintained partially even after 
addition of the detergent. ^ůŝŐŚƚůǇ ŵŽƌĞ ŶĞŐĂƚŝǀĞ ɺ-potentials 
were recorded for PR-loaded dendrimersomes compared with 
empty controls 3,4,5-G1 (11c: -12.3±0.5 mV vs. -9.8±0.5 mV) 
and 3,5-G2 (12b: -15.5±1.6 mV vs. -13.3±2.1 mV), and the Z- 
average size of PR-loaded dendrimersomes 11c (92.6±0.5 nm, 
PDI 0.06) and 12b (132.1±2.1 nm, PDI 0.03) was larger than the 
size of empty controls 11c (76.0±0.9 nm, PDI 0.14) and 12b 
(86.4±0.9, PDI 0.05), respectively. This is likely a charge-related 
phenomenon, since the addition of PR (a secondary amine) has 
been reported to expand monolayers with negatively charged 
polar head groups.61 
Conclusions 
In conclusion, we have shown the feasibility of copper(I)-
catalysed azide alkyne cycloaddition (CuAAC) reaction as an 
efficient and time-saving synthetic tool for preparing two 
generations of amphiphilic Janus-dendrimers having a 3,4-, 3,5- 
and 3,4,5-branched skeleton. The straightforward fabrication, 
using a fast injection of dilute ethanol, THF, or acetone solution 
of Janus dendrimer into water, produced unilamellar and 
multilamellar dendrimersomes with extremely narrow size 
distribution, even when annealed at 70 °C. 
The injection of a mixture of Janus-dendrimer and the small-
molecule drug propranolol in dilute ethanol solutions into water 
resulted in simultaneous self-assembly and encapsulation of the 
model drug within dendrimersomes with high loading 
efficiency, measured by the ratio of intensity caused by the self-
quenching of the drug. The robust shelf-life (> 4 mo) of the 
assemblies constructed from a 3,5- or 3,4,5-branched Janus-
dendrimers is remarkable and shows promise for development 
of uniform and injectable colloidal vesicles with sufficient 
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stability for most drug delivery applications. The size of 
dendrimersomes in solution can be tuned by adjusting the final 
concentration, the branching sequence or the organic solvent 
from which Janus-dendrimers are injected. 
The present toolbox for size modulation, accompanied with a 
fast and straightforward drug loading procedure via single-step 
injection in a reproducible fashion provides access to nano-
structures in the 100 nm size range with narrow size distribution 
and high loading efficiency, suitable for intravenous 
administration. Thus, the results presented here open up new 
avenues for colloidal drug delivery systems and facilitate the 
development of application-specific, dual- or even multi-loaded 
dendrimersome-based delivery vehicles for drugs and other 
therapeutics, with further biomedical applications currently 
being investigated. 
Experimental Section 
Materials 
All reagents and solvents were obtained from commercial 
sources (Fluka, Acros Organics, Merck, TCI Europe, Fisher, 
Rathburn and Sigma-Aldrich) and used without prior 
purification unless otherwise stated. Deuterated solvents for 
NMR analysis were purchased from Euriso-top (Saint Aubin 
Cedex, France). Dry dichloromethane and tetrahydrofuran were 
obtained from a solvent drier (MB-SPS-800, neutral alumina; 
MBraun, Germany) and used when necessary. Milli-Q® purified 
water was used in all reactions and measurements (Millipore 
^ǇŶĞƌŐǇhsƵŶŝƚ ? ? ? ? ?Dɏ ?Đŵ ? ? 
 
Preparation of dendrimersomes 
First, 10 mg mL-1 stock solutions in absolute EtOH and 5 mg mL-
1 stock solutions in THF and acetone of each Janus-dendrimer 
were prepared, respectively. Then, 100 µL of the stock solution 
was injected quickly into 1.9 mL of Milli-Q® followed by 5 sec. of 
vortex mixing to obtain a final concentration of 0.5 mg mL-1 (0.9 
mL of Milli-Q® for THF or acetone). Different final 
concentrations of dendrimersomes, ranging from 0.1 ?4.0 mg 
mL-1 (ethanol injection) and 0.1 ?1.0 mg mL-1 (THF and acetone 
injection) into Milli-Q® were obtained. No purification or further 
manipulation was applied. The stability studies using Foetal 
Bovine Serum (FBS) were conducted as follows: 10 µL of 
dendrimer stock solution in ethanol (c = 30 mg mL-1) was 
injected into 90 µL Milli-Q® in plastic cuvettes. The resulting 
dendrimersomes were then diluted to a final concentration of 
300 µg mL-1 by addition of 900 µL of FBS. For each dendrimer, a 
control sample was prepared accordingly. The samples were 
capped and stored at 37 °C for seven days. All the samples and 
controls were measured daily in triplicate by DLS. The Z-average 
size and changes in PDI were calculated from the analysis results 
and plotted using GraphPad Prism v. 6.07 (GraphPad Software, 
Inc., USA). 
 
Nuclear Magnetic Resonance (NMR) spectra  
1H NMR (500 MHz) spectra and proton-decoupled 13C NMR (125 
MHz) spectra were recorded on a 500 MHz Bruker UltraShield 
Plus spectrometer at 25 °C. Additional measurements were 
recorded on a Bruker Avance DPX400 spectrometer equipped 
with a 5 mm BBFO probehead. Hydrogen multiplicity (CH, CH2, 
CH3) was obtained from DEPT 135 experiments. Heteronuclear 
1,५13C connectivity was determined by using HSQC 
experiments. 
 
Dynamic light scattering (DLS) 
Experiments were performed at least in triplicate at 25 °C using 
a Zetasizer® Nano ZS (Malvern Instruments, UK) equipped with 
4 mW He-Ne laser 633 nm and avalanche photodiode 
positioned at 173° to the beam. For the temperature stability 
experiment samples were ramped in 5 °C intervals from 25 °C 
to 70 °C with 30 sec. equilibration time in each temperature 
point. After cooling to 25 °C, the samples were stabilized for 5 
ŵŝŶ ? ďĞĨŽƌĞ ŵĞĂƐƵƌĞŵĞŶƚ ? &Žƌ ƚŚĞ ǌĞƚĂ  ?ɺ ? ƉŽƚĞŶƚŝĂů ?three 
independent measurements were conducted on samples 
injected from EtOH for a final concentration of 0.5 mg mL-1 of 
dendrimer in Milli-Q®. 
 
Cryogenic-Transmission Electron Microscopy (cryo-TEM) 
Imaging was performed in a JEOL JEM-3200FSC liquid helium 
equipment (JEOL Ltd., Japan). Microscopy images were 
processed with public domain software ImageJ 1.48 
(http://rsb.info.nih.gov/ij/). 
 
Confocal microscopy 
Images were obtained with a Leica TCS SP5 MP upright confocal 
microscope equipped with argon (488 nm) and DPSS (561 nm) 
lasers, and using a HCX Plan Apochromat 20x/0.7 water 
immersion objective (Leica Microsystems, Germany). Z-stacks 
from the dendrimersomes were taken with 0.7 µm thickness. 
 
UV spectroscopy 
The fluorescence of the propranolol free base samples was 
measured with an excitation wavelength of 296 nm and an 
emission wavelength of 332 nm. A fluorescence scan of the Nile 
Red samples was conducted with an excitation wavelength of 
552 nm and emission wavelengths between 580 nm and 700 
nm, with an excitation bandwidth of 5 nm. The fluorescence of 
both compounds was measured in a Varioskan Flash 
fluorometer (Thermo Fisher Scientific Inc., USA). 
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